189 related articles for article (PubMed ID: 31793679)
1. Ornithine decarboxylase inhibition downregulates multiple pathways involved in the formation of precancerous lesions of esophageal squamous cell cancer.
Xie Y; Dong CD; Wu Q; Jiang Y; Yao K; Zhang J; Zhao S; Ren Y; Yuan Q; Chen X; Liu Z; Zhao J; Liu K
Mol Carcinog; 2020 Feb; 59(2):215-226. PubMed ID: 31793679
[TBL] [Abstract][Full Text] [Related]
2. Quercetin-3-methyl ether inhibits esophageal carcinogenesis by targeting the AKT/mTOR/p70S6K and MAPK pathways.
Zhao S; Jiang Y; Zhao J; Li H; Yin X; Wang Y; Xie Y; Chen X; Lu J; Dong Z; Liu K
Mol Carcinog; 2018 Nov; 57(11):1540-1552. PubMed ID: 30035335
[TBL] [Abstract][Full Text] [Related]
3. Alpha-difluoromethylornithine inhibits N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in zinc-deficient rats: effects on esophageal cell proliferation and apoptosis.
Fong LY; Pegg AE; Magee PN
Cancer Res; 1998 Dec; 58(23):5380-8. PubMed ID: 9850069
[TBL] [Abstract][Full Text] [Related]
4. Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway.
Fan H; Yu X; Zou Z; Zheng W; Deng X; Guo L; Jiang W; Zhan Q; Lu SH
Carcinogenesis; 2019 Jul; 40(5):669-679. PubMed ID: 30445633
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting cycloxygenase and ornithine decarboxylase by diclofenac and alpha-difluoromethylornithine blocks cutaneous SCCs by targeting Akt-ERK axis.
Arumugam A; Weng Z; Talwelkar SS; Chaudhary SC; Kopelovich L; Elmets CA; Afaq F; Athar M
PLoS One; 2013; 8(11):e80076. PubMed ID: 24260338
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma.
Li SH; Chen CH; Lu HI; Huang WT; Tien WY; Lan YC; Lee CC; Chen YH; Huang HY; Chang AY; Lin WC
Surgery; 2015 Mar; 157(3):570-80. PubMed ID: 25726316
[TBL] [Abstract][Full Text] [Related]
7. Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells.
Manni A; Wechter R; Gilmour S; Verderame MF; Mauger D; Demers LM
Int J Cancer; 1997 Jan; 70(2):175-82. PubMed ID: 9009157
[TBL] [Abstract][Full Text] [Related]
8. Alterations in transforming growth factor-alpha and epidermal growth factor receptor expression during rat esophageal tumorigenesis.
Wang QS; Sabourin CL; Bijur GN; Robertson FM; Stoner GD
Mol Carcinog; 1996 Feb; 15(2):144-53. PubMed ID: 8599581
[TBL] [Abstract][Full Text] [Related]
9. Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma.
Gong F; Hou G; Liu H; Zhang M
Med Oncol; 2015 Feb; 32(2):455. PubMed ID: 25579166
[TBL] [Abstract][Full Text] [Related]
10. Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC.
Kim DJ; Lee MH; Liu K; Lim DY; Roh E; Chen H; Kim SH; Shim JH; Kim MO; Li W; Ma F; Fredimoses M; Bode AM; Dong Z
Carcinogenesis; 2017 Oct; 38(11):1136-1146. PubMed ID: 29029040
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma.
Lu Z; Peng K; Wang N; Liu HM; Hou G
J Immunol Res; 2016; 2016():7828916. PubMed ID: 27595116
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma.
Li LY; Li EM; Wu ZY; Huang X; Shen JH; Xu XE; Wu JY; Huang Q; Xu LY
Dis Esophagus; 2011 Jul; 24(5):337-45. PubMed ID: 21143696
[TBL] [Abstract][Full Text] [Related]
13. Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling.
Mohammed A; Janakiram NB; Madka V; Ritchie RL; Brewer M; Biddick L; Patlolla JM; Sadeghi M; Lightfoot S; Steele VE; Rao CV
Cancer Prev Res (Phila); 2014 Dec; 7(12):1198-209. PubMed ID: 25248858
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic transition trajectory and potential mechanisms of N-nitrosomethylbenzylamine induced esophageal squamous cell carcinoma in rats.
Zhao C; Zhang H; Zhou J; Liu Q; Lu Q; Zhang Y; Yu X; Wang S; Liu R; Pu Y; Yin L
Ecotoxicol Environ Saf; 2022 Oct; 244():114071. PubMed ID: 36113270
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z
Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164
[TBL] [Abstract][Full Text] [Related]
17. Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase.
Mai S; Liu L; Jiang J; Ren P; Diao D; Wang H; Cai K
Cell Prolif; 2021 Feb; 54(2):e12960. PubMed ID: 33305406
[TBL] [Abstract][Full Text] [Related]
18. OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.
Peng KZ; Ke Y; Zhao Q; Tian F; Liu HM; Hou G; Lu Z
Biochem Pharmacol; 2017 Sep; 140():16-27. PubMed ID: 28539264
[TBL] [Abstract][Full Text] [Related]
19. Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.
Koomoa DL; Yco LP; Borsics T; Wallick CJ; Bachmann AS
Cancer Res; 2008 Dec; 68(23):9825-31. PubMed ID: 19047162
[TBL] [Abstract][Full Text] [Related]
20. Alpha-difluoromethylornithine induction of apoptosis: a mechanism which reverses pre-established cell proliferation and cancer initiation in esophageal carcinogenesis in zinc-deficient rats.
Fong LY; Nguyen VT; Pegg AE; Magee PN
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):191-9. PubMed ID: 11303587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
